Cargando…

Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients at Cardiovascular Risk

BACKGROUND: It has been unclear whether statin therapy directly improves coronary flow reserve (CFR) in hypertensive patients at cardiovascular risk, independent of lifestyle modification and antihypertensive medications. METHODS: In this double-blind, randomized controlled trial, we randomly assign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yujin, Hwang, EunSoon, Lee, Seung-Ah, Lee, Sahmin, Kim, Dae-Hee, Song, Jong-Min, Kang, Duk-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Echocardiography 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318809/ https://www.ncbi.nlm.nih.gov/pubmed/34080332 http://dx.doi.org/10.4250/jcvi.2020.0244

Ejemplares similares

Addition of Amlodipine or Valsartan for Improvement of Diastolic Dysfunction Associated with Hypertension
por: Oh, Jin Kyung, et al.
Publicado: (2020)

Non-randomized comparison between revascularization and deferral for intermediate coronary stenosis with abnormal fractional flow reserve and preserved coronary flow reserve
por: Shin, Doosup, et al.
Publicado: (2021)

Prognostic Impact of Coronary Flow Reserve in Patients With CKD
por: Park, Sugeon, et al.
Publicado: (2022)

Physiologic Assessment of Coronary Artery Disease: Focus on Fractional Flow Reserve
por: Hwang, Doyeon, et al.
Publicado: (2016)

Microvesicles in plasma reflect coronary flow reserve in patients with cardiovascular disease
por: Bryl-Górecka, Paulina, et al.
Publicado: (2021)

Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020)

Angiography‐Based Machine Learning for Predicting Fractional Flow Reserve in Intermediate Coronary Artery Lesions
por: Cho, Hyungjoo, et al.
Publicado: (2019)

Impact of a Geometric Correction for Proximal Flow Constraint on the Assessment of Mitral Regurgitation Severity Using the Proximal Flow Convergence Method
por: Jang, Jeong Yoon, et al.
Publicado: (2018)

Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis
por: Kelshiker, Mihir A, et al.
Publicado: (2021)

Prognosis and Medical Cost of Measuring Fractional Flow Reserve in Percutaneous Coronary Intervention
por: Hong, David, et al.
Publicado: (2022)

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia
por: Rhee, Moo-Yong, et al.
Publicado: (2020)

Impact of height difference between coronary ostium and location of intracoronary pressure sensor on fractional flow reserve measurements
por: Soh, Moon-Seung, et al.
Publicado: (2023)

Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients
por: Jang, Ji-Yong, et al.
Publicado: (2015)

Impaired coronary flow velocity reserve is associated with cardiovascular risk factors but not with angina symptoms
por: Bove, Kira Bang, et al.
Publicado: (2021)

Erratum to: Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis
Publicado: (2022)

Comprehensive assessment of coronary fractional flow reserve
por: Qi, Xiaolong, et al.
Publicado: (2015)

Association of citrullination with the progression of aortic stenosis
por: Kim, Ah-Ram, et al.
Publicado: (2023)

Genome-wide association study of coronary artery calcification in asymptomatic Korean populations
por: Choi, Su-Yeon, et al.
Publicado: (2019)

The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia
por: Rhee, Moo-Yong, et al.
Publicado: (2017)

Rosuvastatin Reduces Blood Viscosity in Patients with Acute Coronary Syndrome
por: Jung, Lae-Young, et al.
Publicado: (2016)

Endothelial and Non-Endothelial Coronary Blood Flow Reserve and Left Ventricular Dysfunction in Systemic Hypertension
por: Rocha, Aloísio Marchi, et al.
Publicado: (2009)

Lower Level of Low Density Lipoprotein Cholesterol is Associated with a Higher Increase in the Fractional Flow Reserve in Patients with Fixed-dose Rosuvastatin
por: Hashikata, Takehiro, et al.
Publicado: (2018)

Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients
por: Jang, Ji-Yong, et al.
Publicado: (2015)

Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases
por: Ji, Eunhye, et al.
Publicado: (2021)

Intravascular ultrasound characteristics in patients with intermediate coronary lesions and borderline fractional flow reserve measurements
por: Yang, Hyoung-Mo, et al.
Publicado: (2018)

Hemodynamic Significance of Coronary Cameral Fistula Assessed by Fractional Flow Reserve
por: Oh, Jun-Hyok, et al.
Publicado: (2012)

Ischemia-based Coronary Revascularization: Beyond Anatomy and Fractional Flow Reserve
por: Lim, Hong-Seok, et al.
Publicado: (2017)

Effect and Safety of Rosuvastatin in Acute Ischemic Stroke
por: Heo, Ji Hoe, et al.
Publicado: (2016)

Discordance between invasive coronary flow reserve (CFR) and non-invasive myocardial flow reserve (MFR) in diffuse coronary ectasia (DCE)
por: Khalil, Mohammed, et al.
Publicado: (2020)

Multiparametric analysis of coronary flow in psoriasis using a coronary flow reserve companion
por: Tona, Francesco, et al.
Publicado: (2021)

Variable Hemodynamic Responses during Diastolic Stress Echocardiography in Patients Who Have Relaxation Abnormality with Possible Elevated Filling Pressure
por: Jang, Jeong Yoon, et al.
Publicado: (2018)

Effect of Patient-Specific Coronary Flow Reserve Values on the Accuracy of MRI-Based Virtual Fractional Flow Reserve
por: Hair, Jackson, et al.
Publicado: (2021)

A vessel length-based method to compute coronary fractional flow reserve from optical coherence tomography images
por: Lee, Kyung Eun, et al.
Publicado: (2017)

Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial
por: Lee, Yong-Joon, et al.
Publicado: (2023)

Rosuvastatin Does Not Affect Fasting Glucose, Insulin Resistance, or Adiponectin in Patients with Mild to Moderate Hypertension
por: Kim, Weon, et al.
Publicado: (2013)

Indirect Radionuclide Coronary Angiography to Evaluate Gradients of Myocardial Blood Flow and Flow Reserve Through Coronary Stenosis Using N-13 Ammonia PET/CT
por: Kim, Hyun-Sik, et al.
Publicado: (2013)

Fractional Flow Reserve following Percutaneous Coronary Intervention
por: Thakur, Udit, et al.
Publicado: (2020)

PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve
por: Haraldsson, Inger, et al.
Publicado: (2019)

Prognostic Impact of Coronary Flow Reserve in Patients With Reduced Left Ventricular Ejection Fraction
por: Joh, Hyun Sung, et al.
Publicado: (2022)

Coronary Flow Reserve and Glycemic Variability in Patients with Coronary Artery Disease
por: Nishi, Takeshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ebd1491q0hrdoq7ago20itok1v